<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
<PublisherName>OICC Press</PublisherName>
<JournalTitle>Progress in Biomaterials</JournalTitle>
<Issn>2194-0517</Issn>
<Volume>13</Volume>
<Issue>1</Issue>
<PubDate PubStatus="epublish">
<Year>2024</Year>
<Month>03</Month>
<Day>30</Day>
</PubDate>
</Journal>
<ArticleTitle>Development and Characterization of ZnO-Loaded Solid Lipid Nanoparticles for Oral Delivery: Physicochemical, Cytocompatibility, and Antibacterial Evaluation</ArticleTitle>
<VernacularTitle></VernacularTitle>
<FirstPage></FirstPage>
<LastPage></LastPage>
<ELocationID EIdType="doi">10.57647/pibm.2024.132402</ELocationID>
<Language>EN</Language>
<AuthorList>
<Author>
<FirstName>Zahra</FirstName>
<LastName>Inanloo</LastName>
<Affiliation>Department of Chemistry, SR.C., Islamic Azad University, Tehran, Iran</Affiliation>
<Identifier Source="ORCID"></Identifier>
</Author>
<Author>
<FirstName>Mohammad</FirstName>
<LastName>Yousefi</LastName>
<Affiliation>Department of Chemistry, TeMS.C., Islamic Azad University, Tehran, Iran</Affiliation>
<Identifier Source="ORCID"></Identifier>
</Author>
<Author>
<FirstName>Sahar</FirstName>
<LastName>Baniyaghoob</LastName>
<Affiliation>Department of Chemistry, SR.C., Islamic Azad University, Tehran, Iran</Affiliation>
<Identifier Source="ORCID"></Identifier>
</Author>
</AuthorList>
<PublicationType>Journal Article</PublicationType>
<History>
<PubDate PubStatus="received">
<Year>2024</Year>
<Month>03</Month>
<Day>30</Day>
</PubDate>
</History>
<Abstract>Chitosan-coated solid lipid nanoparticles loaded with zinc oxide (ZnO-CS-SLNs) were developed to enhance oral zinc delivery and improve formulation performance. The nanoparticles were synthesized via a microemulsion technique and exhibited spherical morphology, an average diameter of 91.2 ± 2.8 nm, a positive zeta potential (+25 mV), and high encapsulation efficiency (90 ± 3%), quantified using ICP-OES. FTIR, DSC, and XRD analyses confirmed structural integrity and uniform ZnO distribution within the lipid matrix. FE-SEM and TEM imaging revealed homogeneous particles with no signs of aggregation. In vitro release studies conducted in simulated gastric (pH 1.2) and intestinal (pH 6.8) fluids demonstrated sustained release profiles reaching up to 93% over 24 hours, consistent with Higuchi kinetics. Cytotoxicity assays on AGS cells indicated excellent biocompatibility, with cell viability exceeding 100% across all tested concentrations. Antibacterial activity of ZnO-002 was validated against Gram-positive and Gram-negative strains using disk diffusion, MIC, and MBC assays. Accelerated stability testing over six months (40 ± 2 °C, 75 ± 5% RH) confirmed the physical and colloidal stability of the formulations. Collectively, these results support ZnO-CS-SLNs as a robust oral delivery system with multifunctional attributes and consistent in vitro performance.</Abstract>
<ObjectList>
<Object Type="keyword">
<Param Name="value">Zinc oxide</Param>
</Object>
<Object Type="keyword">
<Param Name="value">Solid lipid nanoparticles</Param>
</Object>
<Object Type="keyword">
<Param Name="value">Chitosan</Param>
</Object>
<Object Type="keyword">
<Param Name="value">Oral delivery</Param>
</Object>
<Object Type="keyword">
<Param Name="value">Bioavailability</Param>
</Object>
<Object Type="keyword">
<Param Name="value">Antimicrobial activity</Param>
</Object>
<Object Type="keyword">
<Param Name="value">Cytocompatibility</Param>
</Object>
<Object Type="keyword">
<Param Name="value">Sustained release</Param>
</Object>
</ObjectList>
</Article>
</ArticleSet>